Returning in 2019 after a 2018 debut, Phar-East will once again bring together experts from biopharmaceutical companies, regulators, payers and technology innovators to discuss growth opportunities in Asia and the specific requirements for developing and launching drugs in this regional market. The conference will feature sessions on immunotherapy, regulatory affairs and pricing and reimbursement.
